What Is the AGNG ETF? A Complete Guide to Returns, Fees, Holdings, and Alternative ETFs
The Global X Aging Population ETF (AGNG) is a thematic fund that invests in companies expected to benefit from global population aging, with broad exposure to medical devices, pharmaceuticals, biotech, and senior housing REITs. Healthcare concentration, related holdings, and dividend characteristics are the key factors in an investment decision.
What Is the Global X Aging Population ETF?
This thematic ETF tracks a global aging-related index and diversifies across medical device, pharmaceutical, biotech, and senior housing REIT companies expected to see rising demand as the elderly population grows.
It suits investors who want exposure to the long-term structural theme of demographic change and can tolerate a healthcare-centered portfolio.
It is a passively managed (index tracking) ETF operated by Global X.
How Does the Global X Aging Population ETF Invest?
| Item | Details |
|---|---|
| Tracked index | Aging population theme index |
| Management style | Passive (index tracking) |
| Rebalancing frequency | Semiannual |
| Dividend frequency | Semiannual |
| Issuer | Global X |
| Total expense ratio | 0.50% |
The fund selects industries expected to see rising demand from aging and holds related global companies, spreading broadly across medical devices, pharmaceuticals, biotech, and senior housing REITs. Holdings are rebalanced periodically according to the index rules.
- Focus on the long-term theme of demographic change
- Diversified mix spanning healthcare and senior housing
Global X Aging Population ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $96.4M, and the total expense ratio is 0.50% per year.
Compared with broad healthcare ETFs, its portfolio is distinguished by a narrower focus on the aging theme.
Global X Aging Population ETF Performance and Trends
The fund is influenced by healthcare sector trends and the interest rate environment, and its senior housing REIT weighting also adds interest rate sensitivity. Given its thematic nature, returns tend to fluctuate depending on the market phase.
Thematic demand focused on long-term demographic change underpins fund flows, and inflows and outflows can vary with sentiment toward the healthcare sector, the direction of interest rates, and overall market risk appetite.
Global X Aging Population ETF Strengths and Weaknesses
Its strength is exposure to the long-term aging theme, while healthcare concentration and the interest rate sensitivity from REIT holdings are points to watch.
💪 Key Strengths
⚠️ Points to Watch
Global X Aging Population ETF Alternatives and Related Products
The aging theme is closely tied to healthcare exposure, so broader alternatives include products that invest across healthcare, such as XLV and VHT. Narrowing to specific industries, you can also consider IHI for medical devices, IHF for healthcare service providers, and PPH for pharmaceuticals. These funds capture industries that overlap with this product's aging theme in different ways.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| iShares Future Exponential Technologies ETF | $84.24 | +1.0% | $4.0B | 0.46% | 1.01% | +21.9% | |
| State Street SPDR S&P Kensho New Economies Composite ETF | $62.72 | +0.4% | $2.5B | 0.20% | 1.63% | -0.0% | |
| VanEck Agribusiness ETF | $83.71 | +2.4% | $1.1B | 0.56% | 2.15% | +18.8% | |
| Range Nuclear Renaissance Index ETF | $55.90 | -2.1% | $598.7M | 0.85% | 1.03% | -19.9% | |
| VanEck Natural Resources ETF | $73.86 | +1.0% | $321.5M | 0.41% | 1.85% | +31.4% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| NVO | Novo Nordisk ADR | 0.07% | $42.18 | +5.0% | $141.1B | 10.3 | 4.13% |
| JNJ | Johnson & Johnson | 0.04% | $276.32 | +3.8% | $665.2B | 41.9 | 1.93% |
| AZN | Astrazeneca plc | 0.04% | $189.01 | +2.8% | $293.1B | 26.8 | 1.77% |
| LLY | Lilly(Eli) & Co | 0.07% | $1417.99 | +0.6% | $1.33T | 46.6 | 0.48% |
| MRK | Merck & Co Inc | 0.07% | $150.36 | +3.9% | $371.0B | 153.6 | 2.26% |
| ABBV | Abbvie Inc | 0.03% | $294.83 | +3.1% | $521.0B | 50.7 | 2.32% |
| AMGN | AMGEN Inc | 0.03% | $478.23 | +3.7% | $258.5B | 27.7 | 2.11% |
Global X Aging Population ETF Investor Checkpoints
Here are the points to review before investing in AGNG. Because it is a thematic product, it is wise to confirm in advance which industries it is exposed to, how high the fees and interest rate sensitivity are, and how currency effects come into play.
| Checkpoint | What to check | Current status |
|---|---|---|
| 💵 Expense ratio | Check the cumulative cost impact over a long holding period | Annual fee applies |
| 🏥 Industry exposure | Check healthcare and REIT weightings | Healthcare-centered |
| 📉 Interest rate sensitivity | Interest rate impact from REIT holdings | Needs review |
| 💱 Currency | Impact on returns converted into Korean won | Unhedged |
Healthcare policy and regulatory changes and the direction of interest rates are the main factors affecting performance. Given the nature of thematic products, volatility can rise when a specific industry underperforms.
It is a suitable choice for investors who want exposure to the long-term aging theme. If you want to hold healthcare broadly, compare products such as XLV and VHT, and if you prefer concentration in specific industries, compare IHI, PPH, and others.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of July 2, 2026.